First Light Asset Management’s Structure Therapeutics GPCR Stock Holding History

First Light Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-197,350	Closed	-$5.53M	–	38
2025 Q3	$5.53M	Buy	197,350 +75,124	+61%	+$1.5M	0.52%	35
2025 Q2	$2.53M	Sell	122,226 -10,154	-8%	-$223K	0.33%	37
2025 Q1	$2.29M	Sell	132,380 -266,475	-67%	-$6.53M	0.26%	37
2024 Q4	$10.8M	Sell	398,855 -107,367	-21%	-$3.81M	1.04%	26
2024 Q3	$22.2M	Sell	506,222 -84,425	-14%	-$3.26M	1.85%	24
2024 Q2	$23.2M	Buy	590,647 +441,534	+296%	+$18.1M	2.03%	25
2024 Q1	$6.39M	Buy	+149,113	New	+$6.29M	0.49%	41
2023 Q4	–	Sell	-374,412	Closed	-$18.9M	–	77
2023 Q3	$18.9M	Buy	+374,412	New	+$12.1M	1.79%	22

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

First Light Asset Management's GPCR Position: Q4 2025 in Review

First Light Asset Management sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 197,350 shares — an estimated $5.53M sold.

First Light Asset Management first reported a position in GPCR in Q3 2023 and held it in 8 quarters. The position peaked at $23.2M in Q2 2024. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

First Light Asset Management reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
First Light Asset Management sold 197,350 Structure Therapeutics shares in Q4 2025, an estimated $5.53M.
First Light Asset Management first reported a position in Structure Therapeutics in Q3 2023 and held it in 8 quarters.
First Light Asset Management's Structure Therapeutics position peaked at $23.2M in Q2 2024.
197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on First Light Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.